Join
Live feed
·
PRReleasevia Quantisnow
Clene Inc. logo

Clene Announces Biomarker Analyses To Be Included in NDA Submission Supporting ALS Accelerated Approval

ByQuantisnow·Wall Street's wire, on your screen.
CLNN· Clene Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CLNN (Clene Inc.) and more on Quantisnow.